Search results (128)
« Back to PublicationsTargeted Protein Degradation of NUDT5 Dissociates Catalytic Inhibition from Protein Loss in 6-Thioguanine Response.
Journal article
Marques A-SMC. et al, (2026), Nat Commun
Therapeutic targeting of SETD2-deficient cancer cells with the small-molecule compound RITA
Preprint
Humphrey T. et al, (2026)
Advances in BRET probes for intracellular target engagement studies.
Journal article
Capener JL. et al, (2026), Nat Chem Biol
Leveraging E2 ligases for induced proximity and modulation of novel cancer-relevant targets and neosubstrates
Journal article
Chen X. et al, (2026), CANCER RESEARCH, 86
A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis.
Journal article
Nguyen T-A. et al, (2025), Science, 390, 1143 - 1150
A BRET biosensor for measuring uncompetitive engagement of PRMT5 complexes in cells.
Journal article
Rothweiler EM. et al, (2025), Nat Commun, 16
Pharmacological targeting of BMAL1 modulates circadian and immune pathways.
Journal article
Pu H. et al, (2025), Nat Chem Biol, 21, 736 - 745
Drug repurposing in amyotrophic lateral sclerosis (ALS).
Journal article
Carroll E. et al, (2025), Expert Opin Drug Discov, 20, 447 - 464
Bisphosphonates Trigger Anti-Ageing Effects Across Multiple Cell Types and Protect Against Senescence.
Preprint
Lu J. et al, (2025)
Targeted Protein Degradation of NUDT5 Reveals an Unexpected Non-Enzymatic Role in 6-Thioguanine-Mediated Toxicity
Preprint
Marques A-SMC. et al, (2025)
Functional profiling reveals a non-enzymatic role of NUDT5 in repressing purine de novo synthesis
Preprint
Lin J-MG. et al, (2025)
Toward target 2035: EUbOPEN - a public-private partnership to enable & unlock biology in the open.
Journal article
Tredup C. et al, (2025), RSC Med Chem, 16, 457 - 464
Phenomics-Based Discovery of Novel Orthosteric Choline Kinase Inhibitors.
Journal article
Bauer LG. et al, (2025), Angew Chem Int Ed Engl, 64
A Live Cell BRET Probe to Quantify PRMT5-MTA Uncompetitive Target Engagement
Preprint
Rothweiler E. et al, (2025)
